Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	striated muscle myosin thick filament	OBSCN MYBPC3	1.05e-04	4	88	2	GO:0005863
GeneOntologyCellularComponent	myosin filament	OBSCN MYBPC2 MYBPC3	1.55e-04	25	88	3	GO:0032982
GeneOntologyCellularComponent	M band	OBSCN MYBPC2 MYBPC3	2.98e-04	31	88	3	GO:0031430
GeneOntologyCellularComponent	perineuronal net	PTPRZ1 ACAN	7.71e-04	10	88	2	GO:0072534
GeneOntologyCellularComponent	chromosome, telomeric region	TOX4 BRCA2 THOC3 EZH1 SLX4	8.91e-04	176	88	5	GO:0000781
GeneOntologyCellularComponent	perisynaptic extracellular matrix	PTPRZ1 ACAN	9.40e-04	11	88	2	GO:0098966
Domain	Sushi	CD46 C6 CR2 F13B SEZ6	4.52e-06	52	88	5	PF00084
Domain	CCP	CD46 C6 CR2 F13B SEZ6	5.46e-06	54	88	5	SM00032
Domain	SUSHI	CD46 C6 CR2 F13B SEZ6	6.54e-06	56	88	5	PS50923
Domain	Sushi_SCR_CCP_dom	CD46 C6 CR2 F13B SEZ6	7.15e-06	57	88	5	IPR000436
Domain	ARHGEF5_35	ARHGEF35 ARHGEF5	2.19e-05	2	88	2	PF15441
Domain	ARHGEF5/35_N	ARHGEF35 ARHGEF5	2.19e-05	2	88	2	IPR029212
Domain	fn3	FNDC3B PTPRZ1 OBSCN MYBPC2 MYBPC3	1.01e-03	162	88	5	PF00041
Domain	zf-C2H2	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	1.54e-03	693	88	10	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	1.56e-03	694	88	10	IPR013087
Domain	FN3	FNDC3B PTPRZ1 OBSCN MYBPC2 MYBPC3	1.82e-03	185	88	5	SM00060
Domain	FN3	FNDC3B PTPRZ1 OBSCN MYBPC2 MYBPC3	2.50e-03	199	88	5	PS50853
Domain	FN3_dom	FNDC3B PTPRZ1 OBSCN MYBPC2 MYBPC3	3.09e-03	209	88	5	IPR003961
Domain	ZINC_FINGER_C2H2_2	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	3.47e-03	775	88	10	PS50157
Domain	ZINC_FINGER_C2H2_1	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	3.54e-03	777	88	10	PS00028
Domain	Znf_C2H2-like	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	4.19e-03	796	88	10	IPR015880
Domain	GPCR_3	GABBR2 GPR179	4.35e-03	21	88	2	IPR000337
Domain	Znf_C2H2	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	4.53e-03	805	88	10	IPR007087
Domain	ZnF_C2H2	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441 ZNF287	4.65e-03	808	88	10	SM00355
Domain	-	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 PRDM15 ZNF441	4.66e-03	679	88	9	3.30.160.60
Domain	7tm_3	GABBR2 GPR179	4.77e-03	22	88	2	PF00003
Domain	G_PROTEIN_RECEP_F3_2	GABBR2 GPR179	4.77e-03	22	88	2	PS00980
Domain	G_PROTEIN_RECEP_F3_3	GABBR2 GPR179	4.77e-03	22	88	2	PS00981
Domain	G_PROTEIN_RECEP_F3_1	GABBR2 GPR179	4.77e-03	22	88	2	PS00979
Domain	G_PROTEIN_RECEP_F3_4	GABBR2 GPR179	4.77e-03	22	88	2	PS50259
Domain	GPCR_3_C	GABBR2 GPR179	4.77e-03	22	88	2	IPR017978
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	TOX4 CMTR1 BRCA2 GLUL ZNF629 PKM BEND3 SLX4 SYMPK	4.28e-07	357	91	9	37059091
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FSIP2 STIM2 HIVEP2 SASH1 FAM13A ARHGEF5 SVIL SYNE2 ZNF629 FAM53B KIF13A TRAPPC9	2.58e-06	861	91	12	36931259
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HIVEP3 PARP4 STIM2 TOX4 CMTR1 ZNF629 RNF213 TRAPPC9 SLX4	6.02e-06	493	91	9	15368895
Pubmed	Identification of novel interactions between domains of Myosin binding protein-C that are modulated by hypertrophic cardiomyopathy missense mutations.	MYBPC2 MYBPC3	6.77e-06	2	91	2	12386147
Pubmed	Uncoupling of growth plate maturation and bone formation in mice lacking both Schnurri-2 and Schnurri-3.	HIVEP3 HIVEP2	6.77e-06	2	91	2	20404140
Pubmed	Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.	OBSCN MYBPC3	6.77e-06	2	91	2	19403693
Pubmed	Differential methylation of CpG sites in two isoforms of myosin binding protein C, an important hypertrophic cardiomyopathy gene.	MYBPC2 MYBPC3	6.77e-06	2	91	2	20740642
Pubmed	Glutamine synthetase stability and subcellular distribution in astrocytes are regulated by γ-aminobutyric type B receptors.	GLUL GABBR2	6.77e-06	2	91	2	25172509
Pubmed	Lack of Association of Polymorphism Located Upstream of ABCA1 (rs2472493), in FNDC3B (rs7636836), and Near ANKRD55-MAP3K1 Genes (rs61275591) in Primary Open-Angle Glaucoma Patients of Saudi Origin.	FNDC3B ABCA1	6.77e-06	2	91	2	36980976
Pubmed	Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties.	HIVEP3 HIVEP2	6.77e-06	2	91	2	2247438
Pubmed	Muscle Lim Protein and myosin binding protein C form a complex regulating muscle differentiation.	MUC2 MYBPC3	6.77e-06	2	91	2	28867610
Pubmed	Support for a trimeric collar of myosin binding protein C in cardiac and fast skeletal muscle, but not in slow skeletal muscle.	MYBPC2 MYBPC3	6.77e-06	2	91	2	18201573
Pubmed	Understanding the organisation and role of myosin binding protein C in normal striated muscle by comparison with MyBP-C knockout cardiac muscle.	MYBPC2 MYBPC3	6.77e-06	2	91	2	18817784
Pubmed	Dampening of death pathways by schnurri-2 is essential for T-cell development.	HIVEP3 HIVEP2	2.03e-05	3	91	2	21475200
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	PARP4 FBXO10 TOPAZ1 BCORL1 OBSCN PKM RNF213 NCBP1 C6 SYMPK	2.33e-05	736	91	10	29676528
Pubmed	CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation.	CNTNAP2 GABBR2	4.05e-05	4	91	2	25977097
Pubmed	Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia.	OBSCN RNF213	4.05e-05	4	91	2	26147384
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	SOX11 DDIAS PARP4 STIM2 CLTB STON2 CNTNAP2 FAM53B CD46 TRAPPC9	5.44e-05	814	91	10	23251661
Pubmed	Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.	ZFAT ACAN PEAK3	6.03e-05	29	91	3	21998595
Pubmed	Differential expression of C-protein isoforms in developing and degenerating mouse striated muscles.	MYBPC2 MYBPC3	6.74e-05	5	91	2	10024132
Pubmed	Isoform transitions of the myosin binding protein C family in developing human and mouse muscles: lack of isoform transcomplementation in cardiac muscle.	MYBPC2 MYBPC3	6.74e-05	5	91	2	9440711
Pubmed	Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1.	CD46 CR2	6.74e-05	5	91	2	9799332
Pubmed	RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.	PTPRZ1 ACAN	6.74e-05	5	91	2	22728091
Pubmed	Risk of non-Hodgkin lymphoma in association with germline variation in complement genes.	CD46 C6 CR2	7.39e-05	31	91	3	19344414
Pubmed	Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.	CD46 C6 CR2	8.13e-05	32	91	3	18842294
Pubmed	Identification of UHRF1/2 as new N-methylpurine DNA glycosylase-interacting proteins.	OBSCN PKM NCBP1	1.37e-04	38	91	3	23537643
Pubmed	Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.	PTPRZ1 ACAN	1.41e-04	7	91	2	21976490
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	HIVEP3 OBSCN BEND3 RNF213	1.47e-04	101	91	4	10997877
Pubmed	Aly and THO are required for assembly of the human TREX complex and association of TREX components with the spliced mRNA.	NCBP1 THOC3	1.88e-04	8	91	2	23222130
Pubmed	Zfp521 is a target gene and key effector of parathyroid hormone-related peptide signaling in growth plate chondrocytes.	ACAN ZNF521	1.88e-04	8	91	2	20951345
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	FSIP2 ZNF570 ARHGEF5 BCORL1 NCBP1 HERC2 THOC3 PRDM15	1.98e-04	608	91	8	36089195
Pubmed	Novel gene function revealed by mouse mutagenesis screens for models of age-related disease.	ABCA1 ACAN HERC2	2.12e-04	44	91	3	27534441
Pubmed	Tenascin C regulates proliferation and differentiation processes during embryonic retinogenesis and modulates the de-differentiation capacity of Müller glia by influencing growth factor responsiveness and the extracellular matrix compartment.	PTPRZ1 GLUL	2.41e-04	9	91	2	22691363
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	FNDC3B PARP4 ZFAT SYNE2 OBSCN PKM MYBPC2	3.36e-04	497	91	7	23414517
Pubmed	Proteomic and functional evidence for a P2X7 receptor signalling complex.	PTPRZ1 SVIL	3.67e-04	11	91	2	11707406
Pubmed	Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling.	MYBPC2 MYBPC3	3.67e-04	11	91	2	30410445
Pubmed	Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma.	FNDC3B ABCA1	4.39e-04	12	91	2	25173106
Pubmed	Hepatocyte growth factor-regulated tyrosine kinase substrate is essential for endothelial cell polarity and cerebrovascular stability.	PODXL KIF13A	4.39e-04	12	91	2	32044971
Pubmed	Molecular diversity of myofibrillar proteins: gene regulation and functional significance.	MYBPC2 MYBPC3	4.39e-04	12	91	2	8618961
Pubmed	Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication.	NCBP1 THOC3	4.39e-04	12	91	2	18974867
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	PODXL SVIL BCORL1 CAPZA2 CR2 PRDM15 SEZ6 SYMPK	4.57e-04	689	91	8	36543142
Pubmed	Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c.	CD46 CR2	5.18e-04	13	91	2	16002709
Pubmed	Novel Regulatory Mechanisms for the SoxC Transcriptional Network Required for Visual Pathway Development.	SOX11 GLUL	5.18e-04	13	91	2	28411269
Pubmed	Human mRNA export machinery recruited to the 5' end of mRNA.	NCBP1 THOC3	5.18e-04	13	91	2	17190602
Pubmed	Opposing Effects of Growth and Differentiation Factors in Cell-Fate Specification.	SOX11 GLUL	5.18e-04	13	91	2	31155355
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	ASAH1 PTPRZ1 ACAN C6 F13B	5.87e-04	257	91	5	16335952
Pubmed	Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.	TOX4 SASH1 SVIL PKM	6.31e-04	148	91	4	22898364
Pubmed	Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis.	FAM13A MUC2	6.95e-04	15	91	2	23583980
Pubmed	The endoplasmic reticulum stress response in aging and age-related diseases.	MBTPS1 PPP1R15A	6.95e-04	15	91	2	22934019
Pubmed	Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects.	ABCA1 ASAH1 CR2	7.35e-04	67	91	3	16806233
Pubmed	Dual role of Fam208a during zygotic cleavage and early embryonic development.	SVIL NCBP1	7.93e-04	16	91	2	34216590
Pubmed	Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers.	PTPRZ1 CNTNAP2	7.93e-04	16	91	2	21745462
Pubmed	Global comparative transcriptome analysis of cartilage formation in vivo.	SOX11 ACAN	7.93e-04	16	91	2	19272164
Pubmed	Elucidation of the Fanconi Anemia Protein Network in Meiosis and Its Function in the Regulation of Histone Modifications.	BRCA2 SLX4	7.93e-04	16	91	2	27760317
Pubmed	Functional proteomics mapping of a human signaling pathway.	STIM2 TOX4 SASH1 GLUL HERC2 PPP1R15A KIF13A	9.33e-04	591	91	7	15231748
Pubmed	DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2.	CAPZA2 PKM NCBP1	9.44e-04	73	91	3	35973989
Pubmed	Comparison of expression patterns between CREB family transcription factor OASIS and proteoglycan core protein genes during murine tooth development.	PTPRZ1 ACAN	1.01e-03	18	91	2	12684764
Pubmed	Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.	ENPP3 C6	1.12e-03	19	91	2	23149075
Pubmed	Site-1 protease is essential for endochondral bone formation in mice.	MBTPS1 ACAN	1.12e-03	19	91	2	18025304
Pubmed	UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.	RNF213 HERC2	1.38e-03	21	91	2	37422473
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	LDLRAP1 FNDC3B SYNE2 IL21 CD46 C6 CR2 F13B	1.45e-03	824	91	8	20237496
Pubmed	SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function.	SOX11 GLUL	1.51e-03	22	91	2	17084361
Pubmed	Cartilage-specific ablation of site-1 protease in mice results in the endoplasmic reticulum entrapment of type IIb procollagen and down-regulation of cholesterol and lipid homeostasis.	MBTPS1 ACAN	1.51e-03	22	91	2	25147951
Pubmed	Lupus nephritis susceptibility loci in women with systemic lupus erythematosus.	HIVEP3 F13B	1.65e-03	23	91	2	24925725
Pubmed	Fanconi Anemia	BRCA2 SLX4	1.65e-03	23	91	2	20301575
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	TOX4 PTPRZ1 SVIL SYNE2 CLTB RNF213 NCBP1 HERC2 SYMPK	1.72e-03	1049	91	9	27880917
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	ZNF274 SASH1 BRCA2 C6 KIF13A	1.76e-03	329	91	5	17474147
Pubmed	The B-cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85.	CAPZA2 MYBPC3	1.80e-03	24	91	2	21822214
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	FSIP2 PDK2 CAPZA2 OBSCN MYBPC3	1.81e-03	331	91	5	29199018
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	STIM2 SYNE2 HERC2	1.84e-03	92	91	3	15840729
Pubmed	Interaction of amyotrophic lateral sclerosis/frontotemporal lobar degeneration-associated fused-in-sarcoma with proteins involved in metabolic and protein degradation pathways.	HIVEP3 ABCA1 PKM C6	1.95e-03	201	91	4	25192599
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	LDLRAP1 HIVEP2 CAPZA2 GLUL PKM ZNF521 NCBP1 NCAPH2 HERC2 SLX4	1.96e-03	1285	91	10	35914814
Pubmed	Interactome of the negative regulator of nuclear import BRCA1-binding protein 2.	SYNE2 ZNF521	2.11e-03	26	91	2	25820252
Pubmed	Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice.	ACAN LRRK1	2.11e-03	26	91	2	33905568
Pubmed	Identification of 15 loci influencing height in a Korean population.	ACAN FREM1	2.28e-03	27	91	2	19893584
Pubmed	Discovery and refinement of loci associated with lipid levels.	LDLRAP1 ABCA1 FAM13A BRCA2	2.33e-03	211	91	4	24097068
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SASH1 ARHGEF5 FAM53B	2.47e-03	102	91	3	15778465
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZNF629 HERC2 EZH1	2.61e-03	104	91	3	9205841
Interaction	GTSE1 interactions	CMTR1 CLTB CAPZA2 STON2 RNF213 NCAPH2 HERC2 SLX4	5.39e-06	215	90	8	int:GTSE1
Cytoband	7q35	ARHGEF35 ARHGEF5 CNTNAP2	1.83e-04	55	91	3	7q35
Cytoband	Ensembl 112 genes in cytogenetic band chr7q35	ARHGEF35 ARHGEF5 CNTNAP2	3.15e-04	66	91	3	chr7q35
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	ACAN CD46 C6 CR2 F13B SEZ6	4.88e-08	57	64	6	1179
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	HIVEP3 ZFAT HIVEP2 ZNF274 ZNF570 ZNF629 ZNF521 ZNF747 PRDM15 ZNF441 ZNF287	3.91e-05	718	64	11	28
GeneFamily	Fibronectin type III domain containing	FNDC3B PTPRZ1 OBSCN MYBPC2 MYBPC3	2.55e-04	160	64	5	555
GeneFamily	Complement system\|Sushi domain containing	CD46 C6 CR2	2.78e-04	36	64	3	492
GeneFamily	Fibronectin type III domain containing\|I-set domain containing\|Myosin binding proteins	MYBPC2 MYBPC3	3.41e-04	8	64	2	658
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGEF35 ARHGEF5 OBSCN	1.65e-03	66	64	3	722
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA2 SLX4	2.25e-03	20	64	2	548
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 ASAH1 ADAM15 SVIL CAPZA2 GLUL	2.59e-06	190	91	6	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ABCA1 SASH1 ASAH1 GLUL SLC38A7 IL18BP	3.19e-06	197	91	6	075044c17f1c52008cd3c292c15cbf485b50411e
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg\|ICU-SEP / Disease, condition lineage and cell class	FSIP2 ARHGEF35 FBXO10 ARHGEF5 SYNE2 OBSCN	3.19e-06	197	91	6	c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26
ToppCell	ICU-SEP-Lymphocyte-T_NK-Treg\|ICU-SEP / Disease, Lineage and Cell Type	FSIP2 ARHGEF35 FBXO10 SYNE2 OBSCN	1.21e-05	145	91	5	ee99b58462f955b96d036aa67e343db047d66f64
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDIAS FNDC3B FBXO10 BRCA2 MYBPC3	2.38e-05	167	91	5	0130743084dbcb20e10f96715d30961122150cbf
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDIAS FNDC3B FBXO10 BRCA2 MYBPC3	2.38e-05	167	91	5	7bcae3797d3a0811e7f39885afdfd29ec517f11b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B-Plasma_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DDIAS FNDC3B FBXO10 BRCA2 MYBPC3	2.38e-05	167	91	5	c6f0209a1ad797631fdfa3efab6db6b1d3e8e315
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FNDC3B FAM13A OTOGL ZNF521 LRRK1	2.52e-05	169	91	5	319cba07263bf41fcbcbfecd117f91b729394241
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	HIVEP3 RGS19 FAM53B CR2 MYBPC2	3.24e-05	178	91	5	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	ILEUM-non-inflamed-(7)_Lymphatics\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SOX11 SASH1 PODXL STON2 ZNF521	3.32e-05	179	91	5	99777a8931356d1206b8ab22aaa1b1d5a600b809
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SASH1 PODXL ZNF521 RNF213 KIF13A	3.69e-05	183	91	5	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic\|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	ABCA1 CD177 ASAH1 ENPP3 GLUL	3.99e-05	186	91	5	de55471dd5c842026b409cfebf67fe32f079a011
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PARP4 ARHGEF35 ARHGEF5 SYNE2 CD46	4.41e-05	190	91	5	b855b8b7d3439023390ca44629c1a99f5d4c6801
ToppCell	Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet\|Megakaryo-cells / Lineage, cell class and subclass	LDLRAP1 CAPZA2 PKM TRAPPC9 METTL22	4.64e-05	192	91	5	a061db719d87209b56d074afbdeab37aa0079419
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LDLRAP1 PTPRZ1 GLUL OBSCN THOC3	4.64e-05	192	91	5	5a3c66fc3ae22bd9ac90ca137dee0bcabcd20ab8
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LDLRAP1 PTPRZ1 GLUL OBSCN THOC3	4.64e-05	192	91	5	1f348e23843405abb1f1dc7d739fc5647333de16
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SASH1 PODXL ZNF521 KIF13A	4.76e-05	193	91	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	STIM2 SASH1 PODXL ZNF521 KIF13A	4.76e-05	193	91	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DDIAS BRCA2 ADAM15 STON2 CNTNAP2	4.76e-05	193	91	5	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	REC114 OTOGL SVIL OBSCN MYBPC3	4.87e-05	194	91	5	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCA1 SASH1 ASAH1 STON2 GLUL	4.99e-05	195	91	5	c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 FAM13A ASAH1 GLUL PPP1R15A	4.99e-05	195	91	5	042b4f44f90eb23caadeced43699b51e5195ab04
ToppCell	BL-critical-LOC-Myeloid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B ABCA1 ASAH1 GLUL PPP1R15A	5.24e-05	197	91	5	932a7fae4979b561688e6222505df0f4e510ab11
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 FAM13A ASAH1 GLUL PKM	5.24e-05	197	91	5	24bcd56df43796af2833c7ce37719c76dd299c19
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 FAM13A ASAH1 GLUL PKM	5.24e-05	197	91	5	ea7dd7f90be34d8e5936c9c8d35e0918ae64433b
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-mast_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ENPP3 GLUL ZNF521 PPP1R15A FREM1	5.24e-05	197	91	5	61f909737c5f630beffdd326c6844215643dbdde
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	FNDC3B ASAH1 ADAM15 GLUL PPP1R15A	5.24e-05	197	91	5	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	(4)_Endothelial_cells-(41)_EC-arteriolar\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	SOX11 PODXL ADAM15 CLTB GLUL	5.24e-05	197	91	5	482e3f8926880afed88ed37553ed2b5ed58b8c99
ToppCell	moderate-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	STIM2 ASAH1 PODXL ADAM15 RNF213	5.37e-05	198	91	5	7ecce5e266bb08797088cc8f8309e0c7b48df5c9
ToppCell	NS-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B ABCA1 ASAH1 GLUL PPP1R15A	5.37e-05	198	91	5	e56417073e83061a43b9c41d6232d653904c1e90
ToppCell	NS-critical-LOC-Myeloid\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B ABCA1 ASAH1 GLUL PPP1R15A	5.37e-05	198	91	5	58f2bc88d92550fb0b7c2e46c63c49ec6777001c
ToppCell	NS-critical-d_16-33-Myeloid-Neutrophil\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B ABCA1 ASAH1 GLUL PPP1R15A	5.37e-05	198	91	5	fd5dd6d6d72356d4eac8637350405c69ccb7161c
ToppCell	NS-critical-d_16-33-Myeloid\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B ABCA1 ASAH1 GLUL PPP1R15A	5.37e-05	198	91	5	5602a78068ab6cccd4da1cc5566e68805820a295
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ENPP3 GLUL ZNF521 PPP1R15A FREM1	5.37e-05	198	91	5	a1247a5efd92f95c6227c0e71dc8a0427eb54b7f
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ENPP3 GLUL ZNF521 PPP1R15A FREM1	5.50e-05	199	91	5	a24a319d3ba8f4759f742af27610b4d62e359a2d
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ABCA1 SASH1 ASAH1 GLUL IL18BP	5.50e-05	199	91	5	2649afa3ccda78e9d1df26127b66cbfa0c6cd01d
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PTPRZ1 STON2 ZNF521 KCNE5 SEZ6	5.50e-05	199	91	5	a900ef002e1ae583b70be0253d8c44dae6754916
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LDLRAP1 PTPRZ1 PODXL ADAM15 GLUL	5.50e-05	199	91	5	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LDLRAP1 PTPRZ1 PODXL ADAM15 GLUL	5.50e-05	199	91	5	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LDLRAP1 BRCA2 PTPRZ1 ZNF521 LRRK1	5.63e-05	200	91	5	47791c93d03ee17c1ce17e27f075be4fc6f2590e
ToppCell	metastatic_Lymph_Node-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	FNDC3B ABCA1 ASAH1 GLUL PKM	5.63e-05	200	91	5	4758b96725699641b55a665533adf2d238032b09
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	LDLRAP1 HIVEP2 SYNE2 OBSCN RNF213	5.63e-05	200	91	5	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LDLRAP1 BRCA2 PTPRZ1 ZNF521 LRRK1	5.63e-05	200	91	5	f75d95376a340d467c4392b872b2a2dbdd184556
ToppCell	Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	LDLRAP1 BRCA2 PTPRZ1 ZNF521 LRRK1	5.63e-05	200	91	5	fae26560ba3b0b638b6bcf92f05330824b31d21b
ToppCell	metastatic_Brain-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	FNDC3B ABCA1 ASAH1 GLUL RNF213	5.63e-05	200	91	5	bfb54a8ce44caf01083c6567b236395c6ee1d47a
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	FNDC3B STIM2 ASAH1 ADAM15 ZNF521	5.63e-05	200	91	5	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	RV-03._Atrial_Cardiomyocyte\|RV / Chamber and Cluster_Paper	SVIL IL21 OBSCN MYBPC3	6.40e-05	105	91	4	49e16b11f16e83a7d17d162c14bce991201bcc2a
ToppCell	RV-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	SVIL IL21 OBSCN MYBPC3	1.15e-04	122	91	4	1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	STIM2 CAPZA2 MUC2 MYBPC3	1.34e-04	127	91	4	9bc55cb9f4bddb274930784d12a83b9dceb35cb7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	2.47e-04	149	91	4	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OBSCN GPR179 MYBPC2	2.65e-04	61	91	3	5e855b5462f42b7a1d0bbd518cc11072342ce0cc
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OBSCN GPR179 MYBPC2	2.65e-04	61	91	3	2fc13475581431f82e0b5ef42e18cd29c9787666
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GLYAT PARP4 PEAK3 AGBL3	2.73e-04	153	91	4	d6526d17826470534b766df144c74e73eb83fdad
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	2.87e-04	155	91	4	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	2.87e-04	155	91	4	99e749f7075e2c64e9a0bf91009f95b6969197c8
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FSIP2 PTPRZ1 ACAN KIF13A	2.87e-04	155	91	4	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 OBSCN MYBPC2 MYBPC3	3.01e-04	157	91	4	9021900d9b1a71210c9c414a9d165eaf399eb607
ToppCell	facs-Heart-RA-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD177 OBSCN MYBPC2 MYBPC3	3.01e-04	157	91	4	c8c627ca181856cd31dba4cf073c2be659a49dc1
ToppCell	LPS_only-Myeloid-Monocytes,_Macrophages-T-cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENPP3 C6 SLX4 METTL22	3.09e-04	158	91	4	91d8c93af328c3bbebe1d8f019b94849ebc548c0
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GLYAT MUC2 FREM1	3.19e-04	65	91	3	4382d56d5f71c7acfe35f84db7257aba2a7dd36a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.C1ql3_(VTA_(dorsal_VTA))\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GLYAT MUC2 FREM1	3.19e-04	65	91	3	05b712f83d88e864747cd0229a39aca17321e0f8
ToppCell	droplet-Limb_Muscle-nan-24m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP3 CD177 GPR179 SEZ6	3.24e-04	160	91	4	984990be02642a562f0c60ea99c01f005e7c02c2
ToppCell	343B-Myeloid-Mast_cell\|343B / Donor, Lineage, Cell class and subclass (all cells)	ENPP3 GLUL ADGRF3 PPP1R15A	3.24e-04	160	91	4	133ecae0a894d9a0d49d58859623359096b6f030
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3B SASH1 OTOGL MYBPC3	3.24e-04	160	91	4	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	343B-Myeloid-Mast_cell-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ENPP3 GLUL ADGRF3 PPP1R15A	3.24e-04	160	91	4	a2f09b5955602819c8978f4372130c8ef915cd07
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC3B SASH1 OTOGL MYBPC3	3.24e-04	160	91	4	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA1 BRCA2 ENPP3 ZNF629	3.31e-04	161	91	4	c54010d88f1ecb6e0235bb66084876a4d5bf1ecd
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DDIAS SYNE2 HERC2 ZNF441	3.31e-04	161	91	4	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	LPS-IL1RA-Unknown-Endothelial-Monocytes-Macrophages\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HIVEP2 PODXL SLC38A7 GABBR2	3.47e-04	163	91	4	6b11a3ada8725670d0489f404c8c2175ad3904e9
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDIAS FAM53B CD46 SLX4	3.47e-04	163	91	4	953a7db7e90a913e81002d2141fbbd5f1fdf2197
ToppCell	facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAM53B CD46 CERT1 SLX4	3.47e-04	163	91	4	132aece9c79499b4bb3c2bde68d3d7202e1d8772
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BEND3 LRRK1 FREM1 ZNF441	3.55e-04	164	91	4	d167c7a987b9b35d1e7725c803df4f9cd5380e47
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Htr2c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	3.64e-04	165	91	4	c6b23013d77fa9aa967b76e451c8e42b0a657c30
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOGL CR2 MUC2	3.65e-04	68	91	3	cfd75c373e10b3761666ccd445ba74755efeb95f
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOGL CR2 MUC2	3.65e-04	68	91	3	c25fb921dc83eecdc337353894829ae6b5192353
ToppCell	Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Bcl11b-Inhibitory_Gad1Gad2_Id2.Bcl11b_(Interneuron,_Neurogliaform2)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	OTOGL CR2 MUC2	3.65e-04	68	91	3	712f5f4d3a1e0c0db1a340332876206b93bdac31
ToppCell	ILEUM-non-inflamed-(4)_Mast\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ASAH1 ENPP3 GLUL FREM1	3.81e-04	167	91	4	de0cb257def6049830af068f8f74829a708b810f
ToppCell	ILEUM-non-inflamed-(4)_Mast_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ASAH1 ENPP3 GLUL FREM1	3.81e-04	167	91	4	85b39e05eb6e18e06b47e374d808e479ca65173c
ToppCell	Sigmoid-Macrophage-Macrophage\|Macrophage / Region, Cell class and subclass	FNDC3B ABCA1 SASH1 IL18BP	3.89e-04	168	91	4	bb16e135b6ae0d66615420b61edd6f62f2a3233c
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 OTOGL CNTNAP2 C6	3.98e-04	169	91	4	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	4.07e-04	170	91	4	14aa86a4f526ed6986afcb28c49225522055550c
ToppCell	AT1-AT2_cells-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	CD177 PODXL CNTNAP2 GABBR2	4.16e-04	171	91	4	0b9912f07393aca889db72b40da08e0bc9bc1e8c
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	SASH1 PODXL OBSCN GABBR2	4.16e-04	171	91	4	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PODXL TOPAZ1 ADAM15 ADGRF3	4.25e-04	172	91	4	de9b11ab109d04937186c09772cec9105a935f95
ToppCell	3'_v3-blood-Mast\|blood / Manually curated celltypes from each tissue	ENPP3 GLUL ZNF521 FREM1	4.25e-04	172	91	4	e7a46bbeff749ca59b9f1357409ce1ad59dd22dd
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	4.25e-04	172	91	4	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors\|lymph-node_spleen / Manually curated celltypes from each tissue	OTOGL STON2 ZNF521 FREM1	4.44e-04	174	91	4	6d9bdf4d28ff8ebb66ffd1ccdd6a4fe9440a83f3
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	ZFAT ZNF629 KCNE5 LRRK1	4.54e-04	175	91	4	29fbdfe1d3bfcb063be2bced0128a33176c5b78f
ToppCell	NS-critical-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DDIAS BRCA2 ADAM15 STON2	4.64e-04	176	91	4	7cf1a06ceee1ec06532f44c729c31b4d58e5ea49
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-HSC-MPP\|lymph-node_spleen / Manually curated celltypes from each tissue	OTOGL STON2 ZNF521 KCNE5	4.64e-04	176	91	4	32ed5623b8809b9f1aaf7a42dff9807d9376e9c2
ToppCell	Control-Neuronal_cells-Neuronal_cells\|Control / group, cell type (main and fine annotations)	SASH1 PODXL STON2 ZNF521	4.64e-04	176	91	4	98c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PTPRZ1 SVIL CNTNAP2 SEZ6	4.64e-04	176	91	4	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	Control-Neuronal_cells\|Control / group, cell type (main and fine annotations)	SASH1 PODXL STON2 ZNF521	4.64e-04	176	91	4	c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAM13A ZNF570 PRDM15 AGBL3	4.64e-04	176	91	4	76fdf211bce101e83a27d822cb399487bd107027
ToppCell	5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SASH1 PODXL STON2 ZNF521	4.74e-04	177	91	4	b1775e05c28883a15c56628028770bc59d3233fb
ToppCell	10x5'-GI_large-bowel-Mast\|GI_large-bowel / Manually curated celltypes from each tissue	ABCA1 ASAH1 GLUL FREM1	4.84e-04	178	91	4	d10ed2543c96e1a2373f847e0b82144771e26d07
ToppCell	10x5'-GI_large-bowel-Mast-Mast_cells\|GI_large-bowel / Manually curated celltypes from each tissue	ABCA1 ASAH1 GLUL FREM1	4.84e-04	178	91	4	8fc5f735afa25ae43c2acb1c710ade6e9e093e3c
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PODXL GLUL ZNF521 PPP1R15A	4.94e-04	179	91	4	d16dc58b5b22762a5a3c875563ced18022d08908
ToppCell	390C-Lymphocytic-ILC-ILC-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ZFAT HIVEP2 CMTR1 FAM53B	4.94e-04	179	91	4	3edcd1356e49b1f5514c585861999e079ca5e579
ToppCell	390C-Lymphocytic-ILC-ILC-1\|390C / Donor, Lineage, Cell class and subclass (all cells)	ZFAT HIVEP2 CMTR1 FAM53B	4.94e-04	179	91	4	e7045e27f0eb88f552b31c04b56d78e5ccd7a36c
Drug	Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A	MBTPS1 TOX4 BRCA2 ADAM15 NCAPH2 LRRK1 PPP1R15A GABBR2	1.03e-06	194	90	8	4612_DN
Drug	Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A	BRCA2 PDK2 SVIL CNTNAP2 ZNF747 SLC38A7 NCAPH2	1.20e-05	194	90	7	6656_DN
Drug	ST021200; Down 200; 10uM; PC3; HT_HG-U133A	MBTPS1 TOX4 BRCA2 ADAM15 CNTNAP2 LRRK1 SYMPK	1.24e-05	195	90	7	7493_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A	MBTPS1 BTNL3 ASAH1 ACAN SVIL NCAPH2 TRAPPC9	1.24e-05	195	90	7	1968_DN
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; PC3; HT_HG-U133A	MBTPS1 TOX4 ADAM15 ZNF629 ZNF747 FAM53B PPP1R15A	1.37e-05	198	90	7	1824_DN
Drug	Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A	HIVEP3 LDLRAP1 PDK2 BCORL1 NCAPH2 GABBR2 TRAPPC9	1.37e-05	198	90	7	6489_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SASH1 PODXL PDK2 BCORL1 NCAPH2 TRAPPC9 SYMPK	1.37e-05	198	90	7	2767_DN
Drug	Desipramine hydrochloride [58-28-6]; Down 200; 13.2uM; PC3; HT_HG-U133A	HIVEP3 BRCA2 RGS19 CNTNAP2 FAM53B NCAPH2 EZH1	1.42e-05	199	90	7	6693_DN
Drug	Conessine [546-06-5]; Down 200; 11.2uM; HL60; HT_HG-U133A	HIVEP3 HIVEP2 ADAM15 ZNF747 SLC38A7 NCAPH2 TRAPPC9	1.42e-05	199	90	7	2135_DN
Drug	Furosemide [54-31-9]; Down 200; 12uM; HL60; HG-U133A	LDLRAP1 BTNL3 SVIL CLTB ZNF629 EZH1 TRAPPC9	1.42e-05	199	90	7	1580_DN
Drug	AC1L9N61	GLYAT ADAM15 ACAN MYBPC2 MYBPC3	5.31e-05	102	90	5	CID000449471
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; HL60; HT_HG-U133A	ABCA1 FAM13A GLUL NCBP1 NCAPH2 LRRK1	7.13e-05	176	90	6	1345_DN
Drug	carboxymethyl-CoA	SYNE2 CLTB PKM	8.71e-05	22	90	3	CID000444878
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; HL60; HT_HG-U133A	ABCA1 HIVEP2 ZNF747 SLC38A7 LRRK1 TRAPPC9	1.22e-04	194	90	6	1307_DN
Drug	Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A	ABCA1 FAM13A ADAM15 ACAN SLC38A7 CD46	1.22e-04	194	90	6	2034_UP
Drug	Lynestrenol [52-76-6]; Up 200; 14uM; PC3; HG-U133A	ABCA1 CMTR1 PODXL ACAN NCBP1 METTL22	1.22e-04	194	90	6	1953_UP
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A	TOX4 ADAM15 CNTNAP2 ZNF747 LRRK1 ZNF287	1.22e-04	194	90	6	3795_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Up 200; 7.8uM; PC3; HG-U133A	PDK2 ACAN SVIL CLTB SLC38A7 METTL22	1.29e-04	196	90	6	1958_UP
Drug	Mimosine [500-44-7]; Down 200; 20.2uM; PC3; HT_HG-U133A	HIVEP3 NCBP1 FAM53B NCAPH2 LRRK1 GABBR2	1.29e-04	196	90	6	6703_DN
Drug	Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; HL60; HT_HG-U133A	LDLRAP1 TOX4 SVIL ZNF747 NCAPH2 GABBR2	1.29e-04	196	90	6	2339_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HT_HG-U133A	MBTPS1 RGS19 SVIL ZNF747 FAM53B SYMPK	1.29e-04	196	90	6	1182_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	ACAN CNTNAP2 ZNF747 FAM53B LRRK1 SYMPK	1.29e-04	196	90	6	7502_UP
Drug	Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A	TOX4 ADAM15 BCORL1 ZNF747 SLC38A7 GABBR2	1.29e-04	196	90	6	6445_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; MCF7; HT_HG-U133A	ABCA1 SASH1 PDK2 SLC38A7 PPP1R15A TRAPPC9	1.29e-04	196	90	6	4948_DN
Drug	Cetirizine dihydrochloride [83881-52-1]; Down 200; 8.6uM; PC3; HT_HG-U133A	TOX4 FAM13A ADAM15 CNTNAP2 NCAPH2 LRRK1	1.32e-04	197	90	6	4231_DN
Drug	Bromocryptine mesylate [22260-51-1]; Down 200; 5.4uM; PC3; HT_HG-U133A	MBTPS1 HIVEP2 ADAM15 BCORL1 PPP1R15A GABBR2	1.32e-04	197	90	6	4604_DN
Drug	Chloramphenicol [56-75-7]; Down 200; 12.4uM; PC3; HT_HG-U133A	RABEPK HIVEP2 PDK2 ADAM15 FAM53B PPP1R15A	1.32e-04	197	90	6	1795_DN
Drug	Triprolidine hydrochloride [550-70-9]; Down 200; 12.8uM; PC3; HT_HG-U133A	HIVEP2 BRCA2 SYNE2 ZNF629 GABBR2 EZH1	1.32e-04	197	90	6	7248_DN
Drug	5194442; Down 200; 20uM; MCF7; HT_HG-U133A	MBTPS1 TOX4 HIVEP2 SVIL CD46 NCAPH2	1.32e-04	197	90	6	6558_DN
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; PC3; HT_HG-U133A	LDLRAP1 HIVEP2 ZNF747 FAM53B NCAPH2 GABBR2	1.32e-04	197	90	6	1810_DN
Drug	Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A	TOX4 BTNL3 CNTNAP2 CD46 GABBR2 ZNF287	1.32e-04	197	90	6	3717_UP
Drug	S(-)-terguride hydrogen maleate [37686-85-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	ADAM15 CNTNAP2 ZNF747 NCAPH2 GABBR2 SYMPK	1.36e-04	198	90	6	6473_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; HL60; HT_HG-U133A	FAM13A ZNF747 CD46 NCAPH2 LRRK1 METTL22	1.36e-04	198	90	6	1332_DN
Drug	Cephalexin monohydrate [23325-78-2]; Down 200; 11uM; PC3; HT_HG-U133A	HIVEP3 ABCA1 FAM13A BRCA2 SVIL GABBR2	1.36e-04	198	90	6	4654_DN
Drug	Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A	PODXL PDK2 RGS19 BCORL1 FAM53B EZH1	1.36e-04	198	90	6	2809_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A	ABCA1 HIVEP2 BTNL3 CNTNAP2 LRRK1 ZNF287	1.36e-04	198	90	6	3736_UP
Drug	Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A	HIVEP3 BTNL3 ADAM15 NCAPH2 SYMPK MYBPC3	1.36e-04	198	90	6	7501_DN
Drug	estradiol, USP; Down 200; 0.01uM; HL60; HG-U133A	LDLRAP1 GLYAT ADAM15 ACAN SVIL CERT1	1.36e-04	198	90	6	387_DN
Drug	Xylometazoline hydrochloride [1218-35-5]; Down 200; 14.2uM; PC3; HT_HG-U133A	TOX4 BRCA2 SLC38A7 NCBP1 CD46 PPP1R15A	1.36e-04	198	90	6	2107_DN
Drug	(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A	HIVEP2 ZNF747 FAM53B NCAPH2 GABBR2 TRAPPC9	1.36e-04	198	90	6	5444_DN
Drug	Tolfenamic acid [13710-19-5]; Up 200; 15.2uM; PC3; HT_HG-U133A	ABCA1 ACAN ZNF629 NCAPH2 LRRK1 EZH1	1.40e-04	199	90	6	2120_UP
Drug	Dacarbazine [4342-03-4]; Down 200; 22uM; MCF7; HT_HG-U133A	HIVEP2 PODXL ADAM15 BCORL1 NCBP1 EZH1	1.40e-04	199	90	6	2754_DN
Drug	Pirenzepine dihydrochloride [29868-97-1]; Up 200; 9.4uM; PC3; HT_HG-U133A	ADAM15 BCORL1 SLC38A7 NCAPH2 PPP1R15A SYMPK	1.40e-04	199	90	6	2071_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; HL60; HG-U133A	HIVEP3 MBTPS1 ZNF274 BTNL3 ADAM15 ACAN	1.40e-04	199	90	6	1399_DN
Disease	mean platelet volume	LDLRAP1 TOX4 HIVEP2 FAM13A SVIL SYNE2 BCORL1 IL21 CAPZA2 FAM53B ADGRF3 CERT1 MYBPC3	1.15e-05	1020	89	13	EFO_0004584
Disease	pulse pressure measurement	HIVEP3 GLYAT FNDC3B ZFAT FAM13A ASAH1 PODXL CAPZA2 SLC38A7 RNF213 FAM53B CD46 TRAPPC9 MYBPC3	7.02e-05	1392	89	14	EFO_0005763
Disease	right ventricular ejection fraction measurement	ABCA1 SVIL OBSCN	1.02e-04	30	89	3	EFO_0021816
Disease	Immunoglobulin Deficiency, Late-Onset	IL21 CR2	4.86e-04	11	89	2	C2936665
Disease	Acquired Hypogammaglobulinemia	IL21 CR2	4.86e-04	11	89	2	C2936664
Disease	Common variable immunodeficiency	IL21 CR2	6.87e-04	13	89	2	cv:C0009447
Disease	juvenile polyposis syndrome (implicated_via_orthology)	HIVEP3 HIVEP2	6.87e-04	13	89	2	DOID:0050787 (implicated_via_orthology)
Disease	Pneumoconiosis	PTPRZ1 ACAN	8.00e-04	14	89	2	C0032273
Disease	Bagassosis	PTPRZ1 ACAN	8.00e-04	14	89	2	C0004681
Disease	Fanconi anemia	BRCA2 SLX4	8.00e-04	14	89	2	cv:C0015625
Disease	Common Variable Immunodeficiency	IL21 CR2	9.21e-04	15	89	2	C0009447
Disease	diastolic blood pressure, systolic blood pressure	FNDC3B REC114 ADAM15 ACAN SVIL SLC38A7 FAM53B TRAPPC9	9.52e-04	670	89	8	EFO_0006335, EFO_0006336
Disease	low density lipoprotein cholesterol measurement, physical activity	CNTNAP2 CERT1 PRDM15	1.06e-03	66	89	3	EFO_0003940, EFO_0004611
Disease	hearing loss	SOX11 ACAN NCAPH2	1.11e-03	67	89	3	EFO_0004238
Disease	glaucoma	FNDC3B ABCA1 CNTNAP2 HERC2	1.23e-03	154	89	4	MONDO_0005041
Disease	Bone marrow hypocellularity	BRCA2 SLX4	1.33e-03	18	89	2	C1855710
Disease	Hypercholesterolemia, Familial	LDLRAP1 ABCA1	1.33e-03	18	89	2	C0020445
Disease	emphysema pattern measurement	SVIL TRAPPC9	1.49e-03	19	89	2	EFO_0005850
Disease	eosinophil percentage of leukocytes	HIVEP3 ZFAT HIVEP2 ADAM15 BEND3 FAM53B MUC2 SYMPK	1.88e-03	746	89	8	EFO_0007991
Disease	cup-to-disc ratio measurement	GLYAT SASH1 ADAM15 ZNF521 EZH1 SYMPK	1.94e-03	430	89	6	EFO_0006939
Disease	response to anticonvulsant	SASH1 CNTNAP2 ZNF521	2.19e-03	85	89	3	GO_0036277
Disease	HDL cholesterol change measurement	ABCA1 SYNE2	2.38e-03	24	89	2	EFO_0007805
Disease	central corneal thickness	FNDC3B STON2 FAM53B LRRK1 HERC2	2.47e-03	309	89	5	EFO_0005213
Disease	Fanconi Anemia	BRCA2 SLX4	2.58e-03	25	89	2	C0015625
Disease	primary biliary cholangitis (is_marker_for)	ABCA1 MUC2	2.58e-03	25	89	2	DOID:12236 (is_marker_for)
Disease	HMG CoA reductase inhibitor use measurement	GLYAT ABCA1 BRCA2 CERT1	2.61e-03	189	89	4	EFO_0009932
Disease	Antiglaucoma preparations and miotics use measurement	FNDC3B ABCA1	2.79e-03	26	89	2	EFO_0009944
Disease	Pancytopenia	BRCA2 SLX4	2.79e-03	26	89	2	C0030312

Protein segments in the cluster

Peptide	Gene	Start	Entry
DEEKGTPIFICPVSW	BTNL3	451	Q6UXE8
CPEDASVLTWNVTKA	ADGRF3	431	Q8IZF5
IDEKVQHIDWTPSCP	AGBL3	96	Q8NEM8
WSVPETCFVLNKSSP	CATSPERE	51	Q5SY80
EEGWAPPDCTTQLKA	ADAM15	676	Q13444
EACDTPEHWEAVPQS	ARHGEF5	96	Q12774
DQAWSPKTCDIVIEG	FBXO10	301	Q9UK96
DTPCQAGEEEWTTAP	ABCA1	1426	O95477
CKNKWQPDDVTESLP	BCORL1	1101	Q5H9F3
EACDTPEHWEAVPQS	ARHGEF35	96	A5YM69
AQHAPPWTEDCRKST	ASAH1	21	Q13510
SDLPRQWTPKNTSCD	CD177	36	Q8N6Q3
TAPCPTWKVFDSNEE	REC114	46	Q7Z4M0
IPWPVTCASEKEDSN	RABEPK	301	Q7Z6M1
PSVKDTAVWQAECLP	BEND3	316	Q5T5X7
CLSPVDWDKPDSSGT	LDLRAP1	286	Q5SW96
PALTENDPETWIVCN	CERT1	516	Q9Y5P4
PSPTVAHESNWAKCE	PODXL	331	O00592
DTIVCDSNSTWDPPV	CD46	266	P15529
EDWSDCLSQDPESPK	NCBP1	431	Q09161
SDPTVPCNETRWSQK	MBTPS1	141	Q14703
PDSGNKAEICPWETS	GPR179	1256	Q6PRD1
KAEICPWETSEGAPE	GPR179	1261	Q6PRD1
EAQEATPAKTEICPW	GPR179	1581	Q6PRD1
VCPWEAQEAATSEKA	GPR179	1801	Q6PRD1
PVCETAWAQHTDPSE	LRRK1	1166	Q38SD2
SADWPPPQEKECVAV	HERC2	816	O95714
AKQCPALEVTWPEVE	IL18BP	61	O95998
KDEPSQACAEHEWAP	KCNE5	91	Q9UJ90
VVDKWPDFNTVVVCP	GLYAT	46	Q6IB77
PETASSSWEEKPQCK	FSIP2	6761	Q5CZC0
EEQTTCTTEGWSPEP	F13B	71	P05160
DQPSTSIWECLPEKD	FAM53B	61	Q14153
WKEAPTCPDVSTNPE	MUC2	1021	Q02817
TVAQWLAEACTQPPE	PEAK3	261	Q6ZS72
CHETDSDEWVPPTTQ	DDIAS	856	Q8IXT1
WSPQTKDVEDKSCPA	FREM1	2041	Q5H8C1
PVLCKDPVQEAWAED	PKM	471	P14618
TSPPCTDTVDWIVFK	PTPRZ1	236	P23471
DLSWTESCKPTATEP	PARP4	1286	Q9UKK3
TALCDEKNWEEPIPA	FAM13A	566	O94988
ITPTPLCETAWEEQC	IAH1	131	Q2TAA2
QEAGDWCVPSTEPKN	PDK2	386	Q15119
WEEPQITCTDPTTYK	ACAN	2496	P16112
TFLCEVPQPSTEAAW	OBSCN	351	Q5VST9
ADNTWDPEIPVCEKE	CR2	646	P20023
ANDPKWSTPTKDCTS	BRCA2	3186	P51587
WTPPISNSLTCEKDT	C6	751	P13671
ESCPEGKPEALWVEE	ENPP3	816	O14638
VTLQWSKPEGCSPEE	FNDC3B	491	Q53EP0
LPAPEDVETNCEWSA	IL21	61	Q9HBE4
VWAAKDPSPCVVNSS	MS4A18	206	Q3C1V0
WNTTEPSRTCKDPIE	GABBR2	866	O75899
WTAPSTSQKCDEPLV	CNTNAP2	26	Q9UHC6
SWFPECTTEIPDTQE	CMTR1	156	Q8N1G2
GEEAWKSATPVCEAP	FAM166A	156	Q6J272
KPSTWVSCPGEEENQ	PPP1R15A	216	O75807
WSVQTPDDTKCVLTP	OTOGL	286	Q3ZCN5
WDQCESTVAAPVVDP	KIF13A	896	Q9H1H9
TLDSEPKCVEELPEW	GLUL	46	P15104
PVALDESDPDWCKTA	SOX11	31	P35716
CATPSPEEVQSWAQS	RGS19	76	P49795
TPETPENASECSWVA	SVIL	381	O95425
ECTKNPSFSEEPWLE	SYNE2	2211	Q8WXH0
CETPVSVDSIPLEWD	SYNE2	6406	Q8WXH0
ENSAPVESEPSQWAC	PRDM15	551	P57071
LQSPCVDTAPKSEWE	SLC38A7	26	Q9NVC3
DDLCTDPKVPFSWSQ	METTL22	271	Q9BUU2
SWVTFDDNEVSCPLP	STON2	231	Q8WXE9
CEQVPIATDSEGKPW	SLX4	786	Q8IY92
TDPRPCEVENAVESW	CAPZA2	106	P47755
PASCVKETPDPWQSL	NCAPH2	306	Q6IBW4
ETPGTEWEKVAQLCD	CLTB	186	P09497
GSDSWQENPEEPCSK	RNF213	66	Q63HN8
QENPEEPCSKASWTV	RNF213	71	Q63HN8
KWETATEAPEEPSTQ	ZFAT	1076	Q9P243
KIPGVDPWESSECTD	ZNF441	96	Q8N8Z8
PSPEWETKAQACTPV	ZNF287	236	Q9HBT7
KQWEVPDTASECDSL	STIM2	586	Q9P246
VDVEDDPTCSWPASS	ZNF521	76	Q96K83
WDPAAQDPEVAKCPT	ZNF747	96	Q9BV97
PTAWSCEPVTFEDVT	ZNF274	6	Q96GC6
QLCVVEAPSEPVEWT	EZH1	421	Q92800
ETGDKLWEVQCESPT	THOC3	296	Q96J01
RSPETCASPWQKAES	HIVEP3	2126	Q5T1R4
SCETLEGPQTVDTWP	SASH1	821	O94885
TQPFWDSKEPVCIAA	SEZ6	401	Q53EL9
SVSWKDLDDTFPCPV	TRIM60	41	Q495X7
TEVAAPWTEETVKQC	SYMPK	776	Q92797
WIKPDICASNSAESE	TOPAZ1	931	Q8N9V7
GWEPICETEELTPKQ	ZNF570	86	Q96NI8
HEDSTSKELPPSWFC	TRAPPC9	1121	Q96Q05
APEVVPTPSDWTKAC	ZNF629	96	Q9UEG4
TCDSEISEAPVSPEW	HIVEP2	836	P31629
GCENPPIVSKDWDNE	TOX4	576	O94842
CLEGSEEWVPANTEP	MYBPC2	776	Q14324
SNVGEDSCTVQWEPP	MYBPC3	781	Q14896